Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:359 (16 August), doi:10.1136/bmj.327.7411.359-a
Janice Hopkins Tanne
New York
| The first 150 words of the full text of this article appear below. |
Hormone replacement therapy (HRT) should not be used to prevent coronary heart disease, experts advise, after a study showed that it does not prevent the disease and almost doubles a woman's risk during the first year of use.
Furthermore, HRT does not slow progression of established coronary artery disease.
These findings come from two studies published in the New England Journal of Medicine.
Dr JoAnn Manson and colleagues reported final results of the arm of the Women's Health Initiative trial that compared combined oestrogen and progestogen treatment with placebo (
2003;349: 523-34). The trial, sponsored by the US National Institutes of Health, was stopped in 2002 because the risks of treatment exceeded the benefits (
BMJ
2002;325: 61
"There was no clear heart protection. No subgroup clearly showed evidence of heart disease protection," said Dr Manson, the principal investigator and chairwoman of preventive medicine at Harvard's Brigham
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?